Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling
- PMID: 17185603
- PMCID: PMC1868398
- DOI: 10.1126/science.1135299
Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling
Abstract
Innate immune signals mediated by Toll-like receptors (TLRs) have been thought to contribute considerably to the antibody-enhancing effects of vaccine adjuvants. However, we report here that mice deficient in the critical signaling components for TLR mount robust antibody responses to T cell-dependent antigen given in four typical adjuvants: alum, Freund's complete adjuvant, Freund's incomplete adjuvant, and monophosphoryl-lipid A/trehalose dicorynomycolate adjuvant. We conclude that TLR signaling does not account for the action of classical adjuvants and does not fully explain the action of a strong adjuvant containing a TLR ligand. This may have important implications in the use and development of vaccine adjuvants.
Figures
Comment in
-
Immunology. Mouse studies question importance of toll-like receptors to vaccines.Science. 2006 Dec 22;314(5807):1859-60. doi: 10.1126/science.314.5807.1859a. Science. 2006. PMID: 17185572 No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
